ADVERSE EVENT REPORTING – NON STOP SERVICE

Adverse event reporting – NONSTOP service

If you suspect an adverse reaction associated with the use of the medicinal product, Emselex, please contact us at one of the addresses listed below. Alternatively, you may fill out and send to the address the PDF form and / or electronic form,: “Reporting of suspected serious or unexpected adverse drug effect.” In turn, we will send reports on any adverse effect to the State Institute for Drug Control. Your information on the safety and efficacy of our medicines is very important for us.

Contact persons for the reporting of adverse reactions:

The Qualified Person for Pharmacovigilance (QPPhV)

Quintiles Ireland
Rachel Wallace
rachel.wallace@quintiles.com

The nominated person for pharmacovigilance at the national level

Tomáš Doležal, Ph.D.
+420 724 324 414
dolezas@valueoutcomes.cz

Deputy nominated person

Lada Lžičařová
+420 725 549 805
safety@valueoutcomes.cz

Contact

elva pharma s.r.o., Dr. Janského 599, 252 28 Černošice, Czech Republic,
+420 725 469 468, info@elvapharma.com
Linkedin